Medwave launches new blood pressure module developers kit
9 March 2005
DANVERS, Mass., USA. Medwave, Inc. (Nasdaq: MDWV) has released its new
enhanced OEM module developers kit, which allows medical device
manufacturers to sample the Medwave blood pressure technology in a
development setting without investment in engineering resources or time. The
kits will be sold only to device manufacturers registered with the US Food &
Drug Administration or similar regulatory organizations. Medwave will begin
to sell this solution to prospective OEM partners immediately.
Medwave developed its original MJ23 OEM module pursuant to an agreement
with Nihon Kohden of Tokyo, Japan. The new module is named "Legato", which
in music refers to a smooth and connected style. Legato(TM) is the next
logical step in this product's evolution. Medwave will begin to sell this
solution to prospective OEM partners immediately. Only registered medical
device companies will be able to purchase these Legato development kits.
They are not intended
for use on patients or for diagnostic evaluation.
Tim O'Malley, President and CEO of Medwave, Inc. stated: "We continue to
receive tremendous inquiries from prospective customers for our OEM
solutions. Many of these companies want to have the ability to purchase the
module and use it without having to write user interfaces and invest their
own engineering resources. With the Legato OEM developers kit, they can now
purchase the product, load software from the CD-ROM which is provided in the
kit, and then use the Legato module to sample the product. This should make
their decision-making ability faster and easier. Legato allows the OEM
customer to use the product in a test environment without having to do any
development. As the name implies, it is a smooth connected solution. We
continue to place a great deal of emphasis on this portion of our business,
as the interest in our technology and the solutions it provides clinically
Source: Medwave, Inc.